Obstructive sleep apnea (OSA) is known to be associated with metabolic syndrome, diabetes, hypertension which predispose to cardiovascular disease. Hypoxia due to OSA can predispose an individual to development of endothelial dysfunction. Additionally, imbalance between sympathetic–parasympathetic activity can initiate arrhythmias and result in sudden cardiac death. If OSA is diagnosed early and appropriately treated, we can prevent morbidity and mortality in patients with cardiac disease who also have OSA.
Virend K Somers, David P White, et al. Sleep Apnea and Cardiovascular Disease: Circulation. 2008;118:1080–1111.
Robert Wolk, Abu SM Shamsuzzaman, et al. Obesity, Sleep Apnea, and Hypertension. Hypertension. 2003;42:1067–1074.
Logan AG, Perlikowski SM, et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens. 2001; 19:2271–2277.
Robinson GV, Stradling JR, et al. Obstructive sleep apnoea/hypopnoea syndrome and hypertension. Thorax. 2004;59:1089–1094.
Stephen K Williams, Joseph Ravenell, et al. Resistant Hypertension and Sleep Apnea: Pathophysiologic Insights and Strategic Management. Curr Diab Rep. 2011;11:64–69.
Yu S, Liu F, et al. Effect of revised UPPP surgery on ambulatory BP in sleep apnea patients with hypertension and oropharyngeal obstruction. Clin Exp Hypertens. 2010;32(1):49–53.
Patricia Tung, Elad Anter. Atrial Fibrillation And Sleep Apnea: Considerations For A Dual Epidemic. J Atr Fibrillation. 2016;8(6):1283.
Marin JM, Carrizo SJ, et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005;365:1046–1053.
Martin R Cowie, Holger Woehrle, et al. Adaptive Servo-Ventilation for Central Sleep Apnea in Systolic Heart Failure. N Engl J Med. 2015; 373:1095–1105.
Milleron O, Pillière R, et al. Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study. Eur Heart J. 2004;25:728–734.
Melissa A Daubert, David J Whellan, et al. Treatment of Sleep-Disordered Breathing in Heart Failure Impacts Cardiac Remodelling: Insights from the CAT-HF Trial. Am Heart J. 2018;201:40–48.
Christopher M O'Connor, David J Whellan, et al. Cardiovascular Outcomes With Minute Ventilation–Targeted Adaptive Servo-Ventilation Therapy in Heart Failure The CAT-HF Trial. J Am Coll Cardiol. 2017;69(12):1577–1587.
Piotr Ponikowski, Adriaan A Voors, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). European Heart Journal. 2016;37:2129–2200.
Jidong Zhang, Yu Song, et al. Correlation between coronary artery disease and obstructive sleep apnoea syndrome and analysis of risk factors. Exp Ther Med. 2018;15(6):4771–4776.
Cyrus Kholdani, Wassim H Fares, et al. Pulmonary hypertension in obstructive sleep apnoea: is it clinically significant? A critical analysis of the association and pathophysiology Pulm Circ. 2015;5(2): 220–227.
Bernardo J Selim, Brian B Koo, et al. The Association between Nocturnal Cardiac Arrhythmias and Sleep-Disordered Breathing: The DREAM Study. J Clin Sleep Med. 2016;12(6):829–837.
Fatima Dumas Cintra, Renata Pimentel Leite, et al. Sleep Apnea and Nocturnal Cardiac Arrhythmia: A Populational Study. Arq Bras Cardiol. 2014;103(5):368–374.
Apoor S Gami, Eric J Olson, et al. Obstructive Sleep Apnea and the Risk of Sudden Cardiac Death. J Am Coll Cardiol. 2013;62:610–616.
Kerns E S, Kim E D, et al. Obstructive Sleep Apnea Increases Sudden Cardiac Death in Incident Hemodialysis Patients. Am J Nephrol. 2018; 48:147–156.
